Abstract
The expression of common fragile sites (c‐fra) and frequency of chromosomal aberrations were studied in peripheral lymphocytes of 50 healthy Turkish individuals (26 males and 24 females from 1 to 87 years of age) after induction with aphidicolin (APC), 5′‐fluorodeoxyuridine (FUdR), and caffeine. A correlation was seen between age and the frequency of chromosomal aberrations in APC and caffeine treated cultures, but there were no significant differences in the frequencies of chromosomal aberrations between males and females in any of the treatments. The mean frequency of aberrations induced by FUdR was significantly higher than that induced by APC and caffeine. A chromosome aberration is defined as a fragile site when present in 1% of the cells analyzed from each culture and in at least 50% of the individuals studied. Using these criteria, 12 c‐fra were observed in the three treatments: 1p21, 1q21, 2p11‐q11, 3p14, 4q31, 6q26, 7q22, 7q32, 8q24, 11q23, 16q23, and Xp22. Sites 3p14, 16q23, and Xp22 were the most frequently observed c‐fra, with only the frequency of Xp22 being significantly increased in females in APC treated cultures. The results of these studies are important as a base against which the effects of other clastogenic and environmental agents, as well as genetic background, can be compared.
Similar content being viewed by others
References
Ardisia, C., G. Venti, A. Colozza, C. Breschi, B. Porfirio, S. Davis, M. Tonato & E. Donti, 1993. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. Cancer Genet. Cytogenet. 67: 113–116.
Austin, M.J.F., 1991. Expression of common fragile sites on the X chromosome corresponds with active gene regions. Cancer Genet. Cytogenet. 54: 71–76.
Austin, M.J.F., J.M. Collins, L.A. Corey, W.E. Nance, M.C. Neale, R.M. Schieken & J.A. Brown, 1992. Aphidicolin-inducible common fragile-ste expression: Results from a population survey of twins. Am. J. Hum. Genet. 50: 76–83.
Berger, R., C.D. Bloomfield & G.R. Sutherland, 1985. Report of the committee on chromosome rearrangements in neoplasia and on fragile sites. (8th International Workshop on Human Gene Mapping). Cytogenet. Cell Genet. 40: 490–535.
Braekleer, M.D., B. Smith & C.C. Lin, 1985. Fragile sites and structural rearrangements in cancer. Hum. Genet. 69: 112–116.
Chary-Reddy, S., V.S. Prasad & Y.R. Ahuja, 1994. Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency. Cancer Lett. 86: 111–117.
Craig-Holmes, A.P., L.C. Strong, A. Goodacre & S. Pathak, 1987. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum. Genet. 76: 134–137.
Daniel, A., 1986. Clinical implications and classification of the constitutive fragile sites. Am. J. Med. Genet. 23: 419–427.
Esposito, D., G. Fassina, P. Szabo, P. De Angelis, L. Rodgers, M. Weksler & M. Siniscalco, 1989. Chromosomes of older humans are more prone to aminopterine-induced breakage. Proc. Natl. Acad. Sci. USA 86: 1302–1306.
Fundia, A.F. & I.B. Larripa, 1989. Coincidence in fragile site expression with fluorodeoxyuridine and bromodexyuridine. Cancer Genet. Cytogenet. 41: 41–48.
Fundia, A.F., N.B. Gorla, M.M. Bonduel, O. Azpilicueta, H. Lejarraga, F.S. Muriel & I.B. Larripa, 1992. Increased expression of 5q31 fragile site in a Bloom syndrome family. Hum. Genet. 89: 569–572.
Furuya, T., J. Hagiwara, H. Ochi, H. Tokuhiro, R. Kikawada, T. Karube & S. Watanabe, 1991. Changes of common fragile sites on chromosomes according to the menstrual cycle. Hum. Genet. 86: 471–474.
Glover, T.W., C. Berger, J. Coyle & B. Echo, 1984. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67: 136–142.
Glover, T.W., J. Coyle-Morris & R. Morgan, 1986. Fragile sites: Overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet. Cytogenet. 19: 141–150.
Hecht, F., 1986. Rare, polymorphic, and common fragile sites: a classification. Hum. Genet. 74: 207–208.
Hecht, F. & B.K. Hecht, 1993. Breast cancer, miss America, and fragile sites. Cancer Genet. Cytogenet. 67: 147–148.
Hecht, F., E.H. Tajara, D. Lockwood, A.A. Sandberg & B.K. Hecht, 1988. New common fragile sites. Cancer Genet. Cytogenet. 33: 1–9.
King, C.M., E.S. Gillespie, P.G. McKenna & Y.A. Barnett, 1994. An investigation of mutation as a function of age in humans. Mutation Res. 316: 79–90.
Le Beau, M.M., 1986. Chromosomal fragile sites and cancer-specific rearrangements. Blood 67: 849–858.
Liu, C., G. Wang & P. Li, 1989. The expression frequency of common fragile sites and genetic susceptibilitiy to lung cancers. Cancer Genet. Cytogenet. 42: 107–114.
Jordan, D.K., J.E. Divelbiss, M.H. Waziri, T.L. Burns & S.R. Patil, 1989. Fragile site expression in families with von Hippel-Lindau disease. Cancer Genet. Cytogenet. 39: 157–166.
Marlhens, F., W. Al Achkar, A. Aurias, J. Couturier, V. Volobouev & B. Dutrillaux, 1986. The rate of chromosome breakage is age dependent in lymphocytes of adult controls. Hum. Genet. 73: 290–297.
McAlpine, P.J., T.B. Shows, C. Boucheli, M. Huebner & W.A. Anderson, 1991. The 1991 catalog of mapped genes and report of the nomenclature committee. Human Gene Mapping 11. Cytogenet. Cell Genet. 58: 5–102.
Ohta, M., H. Inoue, M.G. Cotticelli, K. Kastury, C.M. Croce & K. Huebner, 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587–597.
Prieur, M., W. Al Achkar, A. Aurias, M. Ricoul, L. Sabatier & E. Viegas-Pequignot, 1988. Acquired chromosome rearrangements in human lymphocytes: effect of aging. Hum. Genet. 79: 147–150.
Rao, P.N., N.A. Heerema & C.G. Palmer, 1988. Fragile sites induced by FUdR, caffeine, and aphidicolin. Hum. Genet. 78: 21–26.
Shabtai, F., D. Klar, J. Hart & I. Halbrecht, 1985. On the meaning of fragile sites in cancer risk and development. Cancer Genet. Cytogenet. 18: 81–85.
Shridhar, V., I. Wang, R. Rosati, W. Paradee & D.I. Smith, 1997. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene 14: 1269–1277.
Smeets, D. & A. Arest, 1990. Genetic determination of fragile-site expression. Am. J. Hum. Genet. 47: 196–201.
Smeets, D. & G. Merkx, 1990. Neither age nor sex influence the expression of folate sensitive common fragile sites on human chromosomes. Hum. Genet. 86: 76–78.
Smeets, D., J.M.J. Scheres & T.W. Hustinx, 1986. The most common fragile site in man is 3p14. Hum. Genet. 72: 215–220.
Smith, M.A.C., M.H.K. Bortolotto, M.I. Melaragno & J.T. Neto, 1990. Investigation of the effect of hydrogen peroxide on the chromosomes of young and elderly individuals. Mech. Ageing. Dev. 56: 107–115.
Sozzi, G., L. Sard, L.D. Gregorio, A. Marchetti, K. Musso, F. Buttitta, M.L. Veronese, U. Pastorino & M.A. Pierotti, 1997. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 57: 2121–2123.
Stoilov, L.M., L.H.F. Mullenders & A.T. Natarajan, 1994. Caffeine potentiates or protects against radiation-induced DNA and chromosomal damage in human lymphocytes depending on temperature and concentration. Mutat. Res. 311: 169–174.
Sundareshan, T.S. & M. Augustus, 1994. Expression of fragile sites in patients with retinoblastoma, their parents, and unaffected siblings: a study of ten families. Cancer Genet. Cytogenet. 78: 72–77.
Sundareshan, T.S. & M. Augustus, 1996. Normal expression of fra(3)(p14.2) in lymphocytes of lung cancer patients. Cancer Genet. Cytogenet. 89: 82–84.
Sutherland, G.R., 1988. The role of nucleotides in human fragile site expression. Mutat. Res. 200: 207–213.
Sutherland, G.R., 1991. Chromosomal fragile sites. GATA 8: 161–166.
Sugio, Y. & Y. Kuroki, 1989. Family study of common fragile sites. Hum. Genet. 82: 191–193.
Tajara, E.H., C.S. Berger, B.K. Hecht, R.M. Gemmill, A.A. Sandberg & F. Hecht, 1988. Loss of common 3p14 fragile site expression in renal cell carcinoma with deletion breakpoint at 3p14. Cancer Genet. Cytogenet. 31: 75–82.
Tedeschi, B., P. Vernole, M. Sanna Lucia & B. Nicoletti, 1992. Population cytogenetics of aphidicolin-induced fragile sites. Hum. Genet. 89: 543–547.
Toncheva, D., 1991. Fragile sites and spontaneous abortions. Genet. Counsel. 2: 205–210.
Yunis, J.J., 1990. Fragile sites, genomic rearrangements and cancer predisposition. Birth-defects 26: 67–83.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Güven, G.S., Hacihanefioğlu, S. & Cenani, A. Expression of aphidicolin, FUdR and caffeine‐induced fragile sites in lymphocytes of healthy Turkish individuals. Genetica 105, 109–116 (1999). https://doi.org/10.1023/A:1003799927024
Issue Date:
DOI: https://doi.org/10.1023/A:1003799927024